about
Regulation of cellular iron metabolismRoles of bacterial and mammalian siderophores in host-pathogen interactionsThe role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesiumOxidative stress and the homeodynamics of iron metabolismIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesA mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin productionBioavailability of metal ions and evolutionary adaptationCeruloplasmin activity and iron chelation treatment of patients with Parkinson's disease.Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation.Role of intracellular labile iron, ferritin, and antioxidant defence in resistance of chronically adapted Jurkat T cells to hydrogen peroxideTargeting chelatable iron as a therapeutic modality in Parkinson's disease.Free radicals and antioxidants: updating a personal view.Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron.The role of iron in the immune response to bacterial infectionMammalian siderophores, siderophore-binding lipocalins, and the labile iron poolMolecular strategies of microbial iron assimilation: from high-affinity complexes to cofactor assembly systems.Composition of protein supplements used for human embryo culture2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes BHV-1 infection in mammalian cells by interfering with iron homeostasis regulationReduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia.Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rateThe long history of iron in the Universe and in health and disease.Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndromeImpaired iron status in aging researchVacuolar H+-ATPase works in parallel with the HOG pathway to adapt Saccharomyces cerevisiae cells to osmotic stressOxidative stress fuels Trypanosoma cruzi infection in miceProtection by Nitric Oxide Donors of Isolated Rat Hearts Is Associated with Activation of Redox Metabolism and Ferritin Accumulation.Detection of Labile Low-Molecular-Mass Transition Metal Complexes in Mitochondria.Treating thalassemia major-related iron overload: the role of deferiprone.Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cellsMolecular imaging of labile iron(II) pools in living cells with a turn-on fluorescent probe.Generation of oxidant response to copper and iron nanoparticles and salts: Stimulation by ascorbate.Are reactive oxygen species always detrimental to pathogens?Zebrafish in the sea of mineral (iron, zinc, and copper) metabolism.Iron-deficiency anemia secondary to mutations in genes controlling hepcidin.Anticancer activity of metal complexes: involvement of redox processes.Multidimensional control of cell structural robustness.Labile iron in cells and body fluids: physiology, pathology, and pharmacology.Iron-sensitive fluorescent probes: monitoring intracellular iron pools.Molecular regulation of cellular iron balance.Iron transport in the kidney: implications for physiology and cadmium nephrotoxicity.
P2860
Q24610063-33BD87BA-7B4C-4D66-84D5-CBA7CC9DB299Q26784135-051A9F62-558E-4886-B164-BE6715B7D0CEQ26859190-8C3450A8-ACB7-462F-8527-792C1F34B8F9Q28082925-AB5D7339-0FA7-4665-ABCB-138310E72AA0Q28388335-FDF009D4-8694-4E04-8099-E2CD4B084044Q28511945-9AE7C644-12D5-4B38-AC1A-316D48309851Q28655003-CBD1FA2F-99F9-42E2-9703-33707667E7BFQ30944822-0CA35A4C-A65C-403A-92B8-3F390815C4F5Q33555894-4FFC24FA-7EC0-4E20-9F86-A1C91DC11448Q33713928-46E1262D-3249-49DB-8FA0-ECE77B28D1A7Q33768106-D4D2619D-E8A8-4FF3-9DC1-823BEB82E171Q34031638-3F10FCDA-34BD-4D0E-B602-3F0D67C19058Q34146691-9BE78643-56CA-400B-B2D8-21EB00EAABB0Q34155194-B4728468-5376-4C57-BA32-27E6892F1CFBQ34258603-AB8EB87A-5C0E-4F6B-8A30-A0D61FD49048Q34314306-63CA6B6A-7E61-4D08-A9E1-7475A46E2E7DQ34603884-3FC41CF6-628E-40C1-89AE-3F659E05881CQ34631946-D02DDA1D-3FD1-46AA-92D8-805A2FE728A7Q34992619-F5DE4476-D002-4178-AD8E-1FFCF0ED7B25Q35112908-2339E475-1B75-42C7-9C0D-98DB6D40D05EQ35672646-F60CCC06-F6C0-4819-9713-A8DF6365C492Q35743810-0C1BFCE0-8E26-4191-B752-E635B0E4F3FAQ35795910-97C62D5C-04FC-4D31-9DCA-49D4CB301E30Q35804688-121D0736-0E67-4830-955C-A76A23F086F4Q36068270-D68AA3A1-1E57-4FB2-BBC0-5FB951D155AAQ36083563-54517ED2-3E36-4225-ADC4-389A196CE359Q36233011-367B347D-CABA-459D-8EE5-5CAE3078D5D3Q36344669-78576F69-AD21-46FF-B800-581B933C9CE6Q36518614-C2B0B634-5941-4C46-AD40-13D2B1919750Q37336347-7EF7CCE8-BFC4-480D-BA0C-FCF2813FF41AQ37391021-1CE6A162-1CD0-42B7-B450-8D9E4BE94856Q37584947-9FC89190-435D-40D4-A15D-0B57E525FB12Q37621602-360730EC-29E0-4B28-9C75-3C645FB41950Q37810273-AB722916-F5C6-488C-BA2D-39D658C1A302Q37833099-3FEF3C93-DE2C-4A62-8167-9527F8E2819AQ38107864-4838AC06-432C-46EE-9676-080465D780E9Q38198634-3DCB1E07-14B2-45D7-AB6F-74D59D51DCF5Q38260227-F557F22E-4F19-4ADF-ADBC-42A8A2F621D2Q38557699-8AEC6A99-C1CD-4516-93AD-71D5A35AB6E3Q38612279-5CE7CC7C-28BB-4BFB-8B23-F760DCC462C8
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intracellular labile iron.
@en
type
label
Intracellular labile iron.
@en
prefLabel
Intracellular labile iron.
@en
P1476
Intracellular labile iron
@en
P2093
William Breuer
Z Ioav Cabantchik
P304
P356
10.1016/J.BIOCEL.2007.03.010
P577
2007-03-19T00:00:00Z